BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Corrective action for Thromborel S, Dade Behring

Product group In-vitro diagnostics
Reference 02794/04

Dade Behring settles a field corrective action of Thromborel S lot n umber 505698B. The manufacturer has observed cracks in few vials of the affected lot which could affect reagent performance and may result in prolonged clotting times. The manufacturer advised customers to run a control with every vial of reagent to ensure proper performance.

Corrective action for Thromborel S, Dade Behring , Download_VeroeffentlichtAm_EN PDF, 53KB,